#news #biotech After Bristol Myers buyout, MyoKardia’s clinical ops lead jumps ship to Esker Therapeutics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After Bristol Myers buyout, MyoKardia’s clinical ops lead jumps ship to Esker Therapeutics .After Bristol Myers buyout, MyoKardia’s clinical ops lead jumps ship to Esker Therapeutics
badams
Thu, 08/19/2021 – 09:39

from FierceBiotech: Biotech https://ift.tt/3xZhlx1